In fact, substance P inhibitors were already reported to have neuroprotective properties by using a 6-hydroxydopamine model of PD [29], and some fiscalin derivatives obtained by synthesis by Long et al. showed neuroprotective properties in SH-SY5Y cells treated with rotenone [30]. The gene discussed is TAC1; the disease is Parkinson disease.